Outcome Of Using Transfixing K Wire ln DDH With Hypoplastic Head And Severe Generalised Ligamentous Laxity

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-31

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to evaluate the outcome of using transfixing hip k wire in Developmental dysplastic hip in patients with hypoplastic head and severe generalised ligamentous laxity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Arthroscopic-Assisted Reduction of Hip Dislocation Via Sub-Adductor and Anterolateral Portals

NCT06520436

Developmental Dysplasia of the Hip

COMPLETED NA

Arthroscopically Assisted Versus Open Surgical Reduction of the Hip in Patients With Irreducible DDH Before the Walking Age

NCT06408987

Developmental Dysplasia of the Hip

NOT_YET_RECRUITING NA

Soft Tissue Pathology in Hip Dysplasia Before and After Periacetabular Osteotomy

NCT02311166

Hip Dysplasia

COMPLETED

Functional Capacity After Computer Assisted Periacetabular Osteotomy in Patients With Hip Dysplasia

NCT02015247

Hip Dysplasia

COMPLETED NA

AI-assisted Preoperative Planning Technology for THA for DDH

NCT05929105

Developmental Dysplasia of the Hip

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of treatment in developmental dysplasia of the hip (DDH) is to obtain and maintain a stable concentric reduction.

Surgical treatment is done by open reduction through a medial approach or anterolateral approach with pelvic osteotomy,capsulorhaphy, femoral shortening and derotational osteotomy.

Transfixing the femoral head with Kirschner wire during open reduction has long been thought to provide stability to the hip without damaging the femoral head or the acetabulum and to decrease the risk or re-dislocation.

The aim of this study is to assess the effect of transfixing the hip with Kirschner wire during the operative treatment of hip dysplasia in children after the walking age on the final radiological and clinical results and to compare the risks with the benefits of adding this step.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Developmental Dysplasia of the Hip

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

K-wire

k wire transfixing hip

Group Type EXPERIMENTAL

Kirschner wire

Intervention Type PROCEDURE

Transfixing femoral head Kirschner wire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kirschner wire

Transfixing femoral head Kirschner wire

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients older than 1 year and younger than 7
2. Patients with hypoplastic head
3. Patients with severe ligamentous laxity (Beighton score ≥ 4)

Exclusion Criteria

1. Patients younger than 1 year and older than 7 years old.
2. Beighton score \< 4
3. Secondary hip dislocation (neuromuscular disorder) as cerebral palsy , myelodysplasia or arthrogryposis.

Minimum Eligible Age

1 Year

Maximum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes